Equalities Minister Kemi Badenoch, who is herself volunteering for Covid-19 vaccine trials at Guy's and St Thomas' Hospital, said: "The UK is leading the world in the search for a Covid-19 vaccine".
This means that ethnic minorities are under-represented in vaccine clinical trials taking place across the United Kingdom, in contrast to 93 per cent people from non-ethnic minority groups.
About 400 high-risk patients have received that jab, according to the health ministry.
"We need to increase production of our first and now our second vaccine, first of all we should supply the domestic market", Mr Putin said, adding that Russian Federation will also work with foreign partners to make the inoculations.
It adds new financing to the World Bank's Covid-19 emergency response programs that are already reaching 111 countries. The diversity is aimed at providing information on how safe and effective the experimental vaccine is in people of different ages and backgrounds.
"People from more than 200 nations live and work in the UAE", AbdulRahman bin Mohammed al-Owais said in the same statement. Trials are also expected to begin in Venezuela in the near future.
Pfizer plans to test its experimental coronavirus vaccine in kids as young as 12 in an effort to make its late-stage clinical trial more diverse.
Chair of the government's vaccine taskforce, Kate Bingham said: "We want to ensure the data we get actually represents the different people from different backgrounds in the UK".
The NHS Vaccine Registry was launched in July to create a database of people who can be contacted by the NHS to take part in clinical studies, to speed up the development of a safe and effective vaccine.
The firm has now submitted a revised protocol for carrying out the clinical trials, sources told PTI. People who volunteer may be approached by researchers to discuss taking part in research studies in the UK.
The pharmaceutical company had applied to the DCGI seeking permission to conduct phase 3 human clinical trials of the potential vaccine against the coronavirus infection.
Chairman of Siam Bioscience, Satitpong Sukvimol said the company was aiming to have the first batch of vaccines available in the middle of next year.